Filing Details
- Accession Number:
- 0001683168-22-008686
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-29 18:27:49
- Reporting Period:
- 2022-12-29
- Accepted Time:
- 2022-12-29 18:27:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1635077 | Aclarion Inc. | ACON | Services-Medical Laboratories (8071) | 473324725 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1900821 | Paul John Lorbiecki | C/O Aclarion, Inc. 8181 Arista Place, Suite 100 Broomfield CO 80021 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-29 | 4,100 | $0.43 | 4,100 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-12-29 | 18,304 | $0.45 | 22,404 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The Reporting Person purchased common stock on the public market on 12/29/2022.